Register
Login:
Share:
Email Facebook Twitter

Early Stage Investment Opportunities: SyndicateRoom, investing from idea to IPO. Watch here

Share Views Episode 9 - Early Stage Investment Opportunities


Gw Pharmaceuticals Directors Deals



Directors deals for Gw Pharmaceuticals (GWP)


Share Price: 800.00Bid: 800.00Ask: 801.50Change: 10.00 (+1.27%)Riser - Gw Pharm.
Spread: 1.50Spread as %: 0.19%Open: 794.00High: 818.00Low: 792.50Yesterday’s Close: 790.00


Directors Deals for Gw Pharmaceuticals (GWP)
Trade DateActionNotifierPriceCurrencyAmountHolding
13-Sep-16Exercise of option
Trade Notifier Information for GW Pharmaceuticals
Stephen Wright held the position of Research and Development Director at GW Pharmaceuticals at the time of this trade.
 Stephen Wright
28.15GBX198,2885915
13-Sep-16Sell
Trade Notifier Information for GW Pharmaceuticals
Stephen Wright held the position of Research and Development Director at GW Pharmaceuticals at the time of this trade.
 Stephen Wright
8.23USD198,2885915
12-May-16Transfer To
Trade Notifier Information for GW Pharmaceuticals
Geoffrey Guy held the position of Executive Chairman at GW Pharmaceuticals at the time of this trade.
 Geoffrey Guy
437GBX200,00013897852
12-May-16Transfer To
Trade Notifier Information for GW Pharmaceuticals
Geoffrey Guy held the position of Executive Chairman at GW Pharmaceuticals at the time of this trade.
 Geoffrey Guy
437GBX200,00013897852
11-May-16Sell
Trade Notifier Information for GW Pharmaceuticals
Geoffrey Guy held the position of Executive Chairman at GW Pharmaceuticals at the time of this trade.
 Geoffrey Guy
444GBX300,00013797852
10-May-16Sell
Trade Notifier Information for GW Pharmaceuticals
Tom Lynch held the position of Non-Executive Director at GW Pharmaceuticals at the time of this trade.
 Tom Lynch
441GBX50,0002074
31-Mar-16Exercise of option
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
0.1GBX75,6002500
31-Mar-16Sell
Trade Notifier Information for GW Pharmaceuticals
Christopher John Tovey held the position of Chief Operating Officer at GW Pharmaceuticals at the time of this trade.
 Christopher John Tovey
433GBX75,6002500
31-Mar-16Exercise of option
Trade Notifier Information for GW Pharmaceuticals
Stephen Wright held the position of Research and Development Director at GW Pharmaceuticals at the time of this trade.
 Stephen Wright
0.1GBX58,2005915
31-Mar-16Sell
Trade Notifier Information for GW Pharmaceuticals
Stephen Wright held the position of Research and Development Director at GW Pharmaceuticals at the time of this trade.
 Stephen Wright
435GBX58,2005915
22-Dec-15Transfer From
Trade Notifier Information for GW Pharmaceuticals
Adam David George held the position of Finance Director and Secretary at GW Pharmaceuticals at the time of this trade.
 Adam David George
02,06527617
22-Dec-15Exercise of option
Trade Notifier Information for GW Pharmaceuticals
Adam David George held the position of Finance Director and Secretary at GW Pharmaceuticals at the time of this trade.
 Adam David George
0.1GBX3,85627617
18-Dec-15Sell
Trade Notifier Information for GW Pharmaceuticals
Geoffrey Guy held the position of Executive Chairman at GW Pharmaceuticals at the time of this trade.
 Geoffrey Guy
366GBX6,00014297852
10-Dec-15Transfer To
Trade Notifier Information for GW Pharmaceuticals
Geoffrey Guy held the position of Executive Chairman at GW Pharmaceuticals at the time of this trade.
 Geoffrey Guy
0320,00014123648
10-Dec-15Sell
Trade Notifier Information for GW Pharmaceuticals
Tom Lynch held the position of Non-Executive Director at GW Pharmaceuticals at the time of this trade.
 Tom Lynch
451GBX4,27052074


Registered members see more Gw Pharmaceuticals directors deals!
Sign up here.




Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk






Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.